Join Dr. Naveen Bangia and Siemens Healthineers to learn about the newest free light chain testing based on monoclonal antibodies. Join for Part 2 on June 16, when Dr. Bangia leads us through the scientific literature that provides a deeper understanding of free light chain biology in patients with Multiple Myeloma.
Speaking on these findings, Naveen Bangia, Ph.D. Siemens Healthineers, will help you:
- Understand the clinical value of free light chain testing in diagnosis and monitoring of patients with Multiple Myeloma
- Explain the differences in different light chain assays that are available
- Interpret differences in Free Light Chain test results between different methods
Naveen Bangia, Ph.D.
Dr. Bangia earned his PhD at the University of Toronto in Toronto, Canada. After postdoctoral work at Yale University, he started his career as a faculty member at Roswell Park Cancer Center and the University at Buffalo where he performed cancer research in the areas of HLA class I antigen presentation, protein folding, proteasome biology and Multiple Myeloma. In the past 8 years, Dr. Bangia has been working in scientific affairs at Binding Site and now is at Siemens Healthineers. He is an expert in free light chain testing for diagnosis and monitoring of patients with monoclonal gammopathies such as Multiple Myeloma and AL Amyloidosis. He supports laboratories, clinicians and patients through presentations and collaborative studies.